Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stefansson

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Peptides|August 20, 2013
High-throughput Peptide epitope mapping using carbon nanotube field-effect transistorsSteingrimur Stefansson, Martha Knight, Hena H Kwon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2017
Telomere Length Is Predictive of Breast Cancer Risk in <i>BRCA2</i> Mutation CarriersBirna Thorvaldsdottir, Margret Aradottir, Olafur A Stefansson, et al.
Breast Cancer Research : BCR|July 19, 2006
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancerValgerdur Birgisdottir, Olafur A Stefansson, Sigridur K Bodvarsdottir, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriersMargret Aradottir, Sigridur T Reynisdottir, Olafur A Stefansson, et al.
Breast Cancer Research : BCR|October 1, 2011
Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progressionOlafur A Stefansson, Jon G Jonasson, Kristrun Olafsdottir, et al.
JNCI Cancer Spectrum|March 17, 2020
<i>BRCA1</i> Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following ChemotherapyOlafur A Stefansson, Holmfridur Hilmarsdottir, Kristrun Olafsdottir, et al.
Molecular Oncology|December 4, 2014
A DNA methylation-based definition of biologically distinct breast cancer subtypesOlafur A Stefansson, Sebastian Moran, Antonio Gomez, et al.
Cell Reports|April 8, 2014
Linkage of DNA methylation quantitative trait loci to human cancer riskHolger Heyn, Sergi Sayols, Catia Moutinho, et al.
Breast Cancer Research and Treatment|July 17, 2013
Tumour diploidy and survival in breast cancer patients with BRCA2 mutationsLaufey Tryggvadottir, Elinborg J Olafsdottir, Gudridur H Olafsdottir, et al.
Carcinogenesis|October 12, 2012
DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarkerHolger Heyn, F Javier Carmona, Antonio Gomez, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Peptides|August 20, 2013
High-throughput Peptide epitope mapping using carbon nanotube field-effect transistorsSteingrimur Stefansson, Martha Knight, Hena H Kwon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2017
Telomere Length Is Predictive of Breast Cancer Risk in <i>BRCA2</i> Mutation CarriersBirna Thorvaldsdottir, Margret Aradottir, Olafur A Stefansson, et al.
Breast Cancer Research : BCR|July 19, 2006
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancerValgerdur Birgisdottir, Olafur A Stefansson, Sigridur K Bodvarsdottir, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriersMargret Aradottir, Sigridur T Reynisdottir, Olafur A Stefansson, et al.
Breast Cancer Research : BCR|October 1, 2011
Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progressionOlafur A Stefansson, Jon G Jonasson, Kristrun Olafsdottir, et al.
JNCI Cancer Spectrum|March 17, 2020
<i>BRCA1</i> Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following ChemotherapyOlafur A Stefansson, Holmfridur Hilmarsdottir, Kristrun Olafsdottir, et al.
Molecular Oncology|December 4, 2014
A DNA methylation-based definition of biologically distinct breast cancer subtypesOlafur A Stefansson, Sebastian Moran, Antonio Gomez, et al.
Cell Reports|April 8, 2014
Linkage of DNA methylation quantitative trait loci to human cancer riskHolger Heyn, Sergi Sayols, Catia Moutinho, et al.
Breast Cancer Research and Treatment|July 17, 2013
Tumour diploidy and survival in breast cancer patients with BRCA2 mutationsLaufey Tryggvadottir, Elinborg J Olafsdottir, Gudridur H Olafsdottir, et al.
Carcinogenesis|October 12, 2012
DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarkerHolger Heyn, F Javier Carmona, Antonio Gomez, et al.
Pageof 6